Clinical Scorecard: Evaluation of Versius CMR in Pelvic Surgical Procedures: A Multicenter Study on Surgical Setup and Initial Results
At a Glance
Category
Detail
Condition
Pelvic surgical procedures including urologic, gynecological, and general surgery interventions
Key Mechanisms
Use of the Versius CMR robotic surgical system featuring an open console with hand controllers, head-up display, and modular bedside units for enhanced visualization and versatility
Target Population
Patients undergoing pelvic surgeries for oncological (e.g., localized prostate cancer) and non-oncological indications
Care Setting
Operating rooms in tertiary care hospitals with trained multidisciplinary surgical teams
Key Highlights
Versius CMR offers an open console design improving OR communication and ergonomic hand controllers without pedal controls.
In a multicenter retrospective study of 42 pelvic procedures, no intra-operative conversions or strategy changes were required.
Early outcomes showed low complication rates (Clavien II and IIIb), minimal system malfunctions, and acceptable operative metrics.
Guideline-Based Recommendations
Diagnosis
Include pelvic surgical indications such as radical prostatectomy, annexectomy, pelvic organ prolapse repair, and rectopexy.
Exclude procedures like colectomy and hernia repair from Versius pelvic surgery evaluation.
Management
Implement comprehensive Versius training for the entire OR team including online didactics, dry box exercises, and wet lab cadaveric simulations.
Adjust trocar placement based on patient anatomy to optimize surgical access and ergonomics.
Use Versius system with up to 4 bedside units positioned around the operating table for tailored configurations.
Monitoring & Follow-up
Collect intra-operative data including console time, estimated blood loss, number of ports and robotic arms used, and system malfunctions.
Monitor post-operative outcomes such as complications (Clavien–Dindo classification), transfusion rates, length of hospital stay, and 30- and 90-day readmissions.
Evaluate oncological outcomes including positive margin rates and biochemical recurrence in cancer surgeries.
Risks
Potential complications include pelvic hematoma requiring transfusion, urinary tract infections, and port-site herniation.
System malfunctions may require re-activation but were infrequent in the study.
Trocar placement adjustments may be necessary to avoid operative difficulties.
Patient & Prescribing Data
Patients undergoing pelvic surgeries with Versius CMR robotic system for oncological and functional indications
Early clinical use demonstrated feasibility with low conversion rates, manageable complications, and acceptable operative parameters; ongoing data collection is needed for long-term outcomes.
Clinical Best Practices
Ensure multidisciplinary team training on Versius system prior to clinical use.
Customize OR setup and robotic arm positioning according to surgical specialty and patient anatomy.
Prospectively collect and analyze intra- and post-operative data to monitor safety and efficacy.
Maintain readiness to adjust trocar placement intra-operatively to optimize access and reduce complications.
Use the open console design to enhance intraoperative communication among surgical team members.
Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss new results from the PANKU-Breast02 Study on a new dual-antibody drug conjugate, called izalontamab brengitecan (iza-bren), for metastatic triple-negative breast cancer.
Christopher Lindblade, MD, co-author of a 2026 Journal of the American Society of Echocardiography study, shares how factors seen on fetal echocardiography support the Phoenix Children’s model for performing urgent bedside balloon atrial septostomy for babies with neonatal hypoxia.
